{"web_url": "http://news.blogs.nytimes.com/2015/07/28/morning-agenda-executive-strategy-at-bank-of-america/", "multimedia": [], "subsection_name": "false", "print_page": null, "blog": [], "section_name": "false", "abstract": "Thwarting the Quick Buck | Bigger is Better in Pharmaceuticals | Greek Preparations for Euro Exit", "type_of_material": "Blog", "lead_paragraph": null, "keywords": [{"value": "Fink, Laurence D", "name": "persons", "rank": "1"}, {"value": "Greece", "name": "persons", "rank": "2"}, {"value": "Icahn, Carl C", "name": "persons", "rank": "3"}, {"value": "Moynihan, Brian T", "name": "persons", "rank": "4"}, {"value": "Varoufakis, Yanis", "name": "persons", "rank": "5"}, {"value": "Clinton, Hillary Rodham", "name": "glocations", "rank": "1"}, {"value": "Wall Street (Manhattan, NY)", "name": "glocations", "rank": "2"}, {"value": "AbbVie Inc", "name": "organizations", "rank": "1"}, {"value": "Hedge Funds", "name": "organizations", "rank": "11"}, {"value": "Honeywell International Inc", "name": "organizations", "rank": "12"}, {"value": "KKR & Co LP", "name": "organizations", "rank": "13"}, {"value": "MasterCard Inc", "name": "organizations", "rank": "14"}, {"value": "Merrill Lynch &amp; Co", "name": "organizations", "rank": "15"}, {"value": "Mylan Inc", "name": "organizations", "rank": "16"}, {"value": "Pfizer Inc", "name": "organizations", "rank": "17"}, {"value": "Private Equity", "name": "organizations", "rank": "18"}, {"value": "Teva Pharmaceutical Industries Ltd", "name": "organizations", "rank": "19"}, {"value": "Visas", "name": "organizations", "rank": "20"}, {"value": "Allergan Inc", "name": "organizations", "rank": "2"}, {"value": "Zurich Insurance Group Ltd.", "name": "organizations", "rank": "21"}, {"value": "Bank of America Corporation", "name": "organizations", "rank": "3"}, {"value": "BlackRock Inc", "name": "organizations", "rank": "4"}, {"value": "Carlyle Group LP", "name": "organizations", "rank": "5"}, {"value": "Countrywide Financial Corp", "name": "organizations", "rank": "6"}, {"value": "Delta Air Lines, Inc", "name": "organizations", "rank": "7"}, {"value": "Drugs (Pharmaceuticals)", "name": "organizations", "rank": "8"}, {"value": "Elster Group SE", "name": "organizations", "rank": "9"}, {"value": "Goldman Sachs Group Inc", "name": "organizations", "rank": "10"}, {"value": "Banking and Financial Institutions", "name": "subject", "rank": "1"}, {"value": "Capital Gains Tax", "name": "subject", "rank": "2"}, {"value": "China", "name": "subject", "rank": "3"}, {"value": "European Sovereign Debt Crisis (2010- )", "name": "subject", "rank": "4"}, {"value": "Initial Public Offerings", "name": "subject", "rank": "5"}, {"value": "Mergers, Acquisitions and Divestitures", "name": "subject", "rank": "6"}, {"value": "Stocks and Bonds", "name": "subject", "rank": "7"}], "_id": "55b7635138f0d860ec81dce2", "pub_date": "2015-07-28T07:07:45Z", "byline": {"original": "By AMIE TSANG", "person": [{"role": "reported", "firstname": "Amie", "organization": "", "rank": 1, "lastname": "TSANG"}]}, "news_desk": null, "slideshow_credits": null, "word_count": "1984", "source": "The New York Times", "headline": {"main": "Morning Agenda: Executive Strategy at Bank of America", "kicker": "News"}, "snippet": "Thwarting the Quick Buck | Bigger is Better in Pharmaceuticals | Greek Preparations for Euro Exit...", "document_type": "blogpost"}